Connection

CHARLES MINARD to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications CHARLES MINARD has written about Antibodies, Monoclonal, Humanized.
  1. Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213). Pediatr Blood Cancer. 2018 05; 65(5):e26944.
    View in: PubMed
    Score: 0.107
  2. A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatr Blood Cancer. 2024 Jun; 71(6):e30938.
    View in: PubMed
    Score: 0.041
  3. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center. Pediatr Transplant. 2016 Feb; 20(1):49-58.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.